IRIS
CATANZARO, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.857
EU - Europa 3.812
AS - Asia 3.335
SA - Sud America 720
AF - Africa 377
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 16.110
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.667
SG - Singapore 1.790
IT - Italia 1.200
RU - Federazione Russa 955
CN - Cina 849
BR - Brasile 608
IE - Irlanda 597
UA - Ucraina 486
VN - Vietnam 239
FR - Francia 185
CI - Costa d'Avorio 177
CA - Canada 154
KR - Corea 109
DE - Germania 101
NG - Nigeria 90
GB - Regno Unito 57
IN - India 51
NL - Olanda 48
SE - Svezia 47
HK - Hong Kong 42
BD - Bangladesh 37
AR - Argentina 35
SN - Senegal 30
IQ - Iraq 29
JP - Giappone 28
MX - Messico 26
PL - Polonia 23
TR - Turchia 23
ID - Indonesia 22
EC - Ecuador 21
ZA - Sudafrica 21
FI - Finlandia 19
ES - Italia 18
CH - Svizzera 17
EG - Egitto 17
UZ - Uzbekistan 17
PK - Pakistan 15
VE - Venezuela 14
CO - Colombia 13
MA - Marocco 13
BE - Belgio 11
TW - Taiwan 10
AT - Austria 9
PH - Filippine 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
MY - Malesia 7
SA - Arabia Saudita 7
BG - Bulgaria 6
BJ - Benin 6
DZ - Algeria 6
JO - Giordania 6
PE - Perù 6
PY - Paraguay 6
UY - Uruguay 6
BO - Bolivia 5
CL - Cile 5
CZ - Repubblica Ceca 5
GR - Grecia 5
NP - Nepal 5
RO - Romania 5
TN - Tunisia 5
AZ - Azerbaigian 4
LB - Libano 4
PS - Palestinian Territory 4
DK - Danimarca 3
ET - Etiopia 3
IL - Israele 3
OM - Oman 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BW - Botswana 2
HN - Honduras 2
IR - Iran 2
JM - Giamaica 2
KE - Kenya 2
KG - Kirghizistan 2
LT - Lituania 2
LU - Lussemburgo 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AL - Albania 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
EE - Estonia 1
EU - Europa 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
Totale 16.102
Salva come PNG Salva come JPEG
Città #
Dallas 1.998
Singapore 1.042
Santa Clara 918
Chandler 555
Dublin 525
Houston 439
Jacksonville 403
San Jose 383
Moscow 375
Ashburn 295
Boardman 224
Chicago 197
Abidjan 177
Catania 150
Cambridge 146
Lawrence 145
Andover 144
Beijing 144
Lauterbourg 138
Nanjing 116
Seoul 108
Los Angeles 105
Milan 103
Toronto 102
Menlo Park 101
Council Bluffs 89
Des Moines 82
Hefei 79
Rome 76
Ho Chi Minh City 72
Wilmington 69
São Paulo 61
The Dalles 58
Abuja 57
San Mateo 57
Columbus 54
Nanchang 51
Hanoi 46
New York 42
Shenyang 42
Civitanova Marche 41
Buffalo 38
Hong Kong 38
Saint Petersburg 36
Dakar 30
Lagos 28
Orem 28
Ottawa 26
Jiaxing 25
Tianjin 24
Tokyo 24
Falls Church 23
Hebei 23
Bremen 21
Changsha 21
Rio de Janeiro 21
Palermo 20
Florence 19
Atlanta 18
Dong Ket 17
Naples 17
Brooklyn 16
Grafing 16
Stockholm 16
Bologna 15
Da Nang 15
Frankfurt am Main 14
Warsaw 14
Phoenix 13
Ann Arbor 12
Baghdad 12
Lappeenranta 12
Amsterdam 11
Bari 11
Belo Horizonte 11
Brasília 11
Brussels 11
Denver 11
Jakarta 11
Johannesburg 11
Norwalk 11
Pune 11
Cairo 10
Curitiba 10
Guayaquil 10
Redondo Beach 10
Taipei 10
Dhaka 9
Genoa 9
Goiânia 9
Jinan 9
Mascalucia 9
Mexico City 9
Poplar 9
Redwood City 9
Washington 9
Chennai 8
Guarulhos 8
Istanbul 8
Liberty Lake 8
Totale 10.934
Salva come PNG Salva come JPEG
Nome #
Potassium-Rich, Gluten-Free Diets for Patients with Sjögren's Syndrome: A Hypothesis 594
Terapia eradicante l'Helicobacter pylori e recidive dell'ulcera duodenale 420
More than a common acid buffering in the treatment of Non-Erosive GERD-like Clinical Spectrum: A Chios Masthia-based Formulation with (Cyto) Protecting Effect 366
Litiasi Biliare e Patologia della Papilla 345
ASSOCIATION OF IRRITABLE BOWEL SYNDROME WITH NON-EROSIVE REFLUX DISEASE 317
A 2-year Double-Blind RCT Follow-up Study with Fermented Papaya Preparation (FPP) Modulating Key Markers in Middle-Age Subjects with Clustered Neurodegenerative Disease-Risk Factors 316
Malattie dell'apparato digerente. Edizione 2025-2028 273
Use of probiotics in the Helicobacter pylori eradication in Italy: data from the Italian Registry on Helicobacter pylori treatment 209
PREVALENCE OF INFLAMMATORY BOWEL DISEASE IN PATIENTS WITH CELIAC DISEASE IN EASTERN SICILY AREA 182
Beneficial effect of refined red palm oil on lipid peroxidation and monocyte tissue factor in HCV-related liver disease: A randomizer controller study 167
La Fenoverina nel trattamento della sindrome del colon irritabile 166
Cholelithiasis and Disorders of the Duodenal Papilla 162
La metodica sierologica per l'Helicobacter pylori a confronto con l'endoscopia nella diagnosi dell'ulcera duodenale, della gastrite cronica antrale e della dispepsia non ulcerosa 153
Antiglycating agents: a short review 149
ADULTHOOD COELlAC DlSEASE lN URBAN AREA OF CATANIA EASTERN SIClLY A RETROSPECTIVE STUDY 147
CLINICAL SIGNIFICANCE OF CYTOMEGALOVIRUS (CMV) INFECTION IN INFLAMMATORY BOWEL DISEASE 143
Advantage of carbonate-versus citrate-based alkalinization on bone metabolism in moderately exercising aged male rats fed an acidogenic diet 142
Beneficial modification of functional renal parameters in 5/6 nephrectomized rats by nutraceutical. In view of a kidney-protective intervention 139
Apparato digerente e sistema epato-biliare: impiego razionale e scientifico della moderna fitoterapia 137
Efficacia della dilatazione pneumatica nella stenosi pilorica: follow-up di 18 mesi 137
Anti-inflammatory and anti-mutagenic effect of the YHK phytocompound in hepatocytes: In view of an age-management liver-protecting approach 136
Autoimmune pancreatitis today: clinical features and diagnostic strategies 133
Clinical Challenges and Images in GI: Image 2, Intestinal Waldenström macroglobulinemia 131
Endoscopic ultrasound-guided fine needle aspiration role in preoperative diagnosis of pancreatic tumors 131
Enhanced liver fibrosis (ELF) test: a prospective study of non-invasive diagnostic method of liver fibrosis 130
Probiotic supplementation in the treatment of Helicobacter pilory infection in Italy: data from Italian registry on H. pylori treatment 129
Beneficial effect of a symbiotic preparation with S. boulardii lysate in mild stress-induced gut hyper-permeability 128
Beneficial Gut Effect of a Symbiotic-Probiotic Regimen in Healthy Stressed Individuals: Effectiveness on Permeability, Microbiota and Detoxification Parameters 128
Beneficial nutraceutical modulation of cerebral erythropoietin expression and oxidative stress: an experimental study 127
A sturgeon-derived bioactive compound beneficially modulates nuclear receptors controlling metabolic functions in patients with metabolic syndrome 126
Benefits of aged garlic extract in modulating toxicity biomarkers against p-dimethylaminoazobenzene and phenobarbital induced liver damage in Rattus norvegicus 126
A serologic survey of Helicobacter pylori infection in 3281 Italian patients endoscoped for upper gastrointestinal symptoms 125
Nutraceutical management of stress-induced redox imbalance and mitochondrial damage 125
Irritable Bowel syndrome: subgroups and relationship with gastroesophageal reflux disease 125
A phytochemical approach to experimental metabolic syndrome-associated renal damage and oxidative stress 124
Overlapping of gastroesophageal reflux disease and irritable Bowel syndrome 123
Digestive diseases. 2022-2025 edition 122
RISK FACTORS OF COLORECTAL POLYPS IN MALE POPULATION OF SOUTH-EASTERN SICILY 122
Benign pancreatic hyperenzymemia, Gullo’s syndrome. Focus on this clinical challenge: a monocentric retrospective study 121
Sintomi indicativi della dispepsia non-ulcerosa Helicobacter Pylori positiva 120
Beneficial effect of a sturgeon-based bioactive compound on gene expression of tumor necrosis factor-alpha, matrix metalloproteinases and type-10 collagen in human chondrocytes 119
The gut microbiota and its correlations with the central nervous system disorders 117
Anti-aging and Rejuvenation Based on Stem Cell Therapy 114
Current practice of gastroenterologist in th etreatment of Helicobacter pylori infection in Italy: data from Italian Registry on H. pylory treatment 114
Blood tests in the management of Helicobacter pylori infection 113
Colorectal Endoscopic Polipectomy: A Retrospective Study 113
Non-Ulcer Dyspepsia Symptoms After Eradication Of Campylobacter Pylori 112
The relationship between serum uric acid and non alcoholic fatty liver disease: a cross-sectional retrospective study 111
Effect of Integrated Nutraceutical Formula on Key Inflammatory Regulators in Subjects with Metabolic Syndrome Features: A Randomized, Double-Blind Study 109
Efficacy of pneumatic dilatation for pyloric stenosis: an 18-month survey 108
Oxidative Stress and Smoke-Related Lung Diseases: A Tentative Approach Through the Blood, Lungs, and Gut 105
Terapia eradicante l'Helicobacter Pylori e recidive dell'ulcera duodenale 104
Colonoscopy technique with an external straightener 103
EVALUATION OF CROHN'S DISEASE ACTIVITY BY DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING (MRI) 103
Helicobacter pylori positive dyspepsia: results after six month suspension omeprazole/amoxicillin combined therapy 102
Clinical significance of cytomegalovirus (CMV) infection in inflammatory bowel disease 101
Gut Microbiota and Aging: Targets and Anti-aging Interventions 101
Non alcoholic fatty liver disease: prevalence of gastroesophageal refux disease symptoms 99
Helicobacter pylori eradication in elderly patients: comparison of two treatments 99
Linfoma non-Hodgkin ad esordio digiunale (stadio II E 2). Follow-up a medio termine di un caso trattato con chirurgia e terapia sistemica 98
PANCREATIC MASSES: VALUE OF ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE ASPIRATION IN CLINICAL PRACTICE 97
In vitro protective effect of Celergen, a bioactive marine compound, on interleukin-6-related invasiveness of pancreatic cancer 95
Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease 95
Effect of VBC‑1814/7J, a poly‑phytocompound, on a non‑infectious model of pharyngitis 94
Ernia Hiatale Da Scivolamento Ed Esofagite Da Reflusso-Studio Retrospettivo 93
Gut-Targeted Immunonutrition Boosting Natural Killer Cell Activity Using Saccharomyces boulardii Lysates in Immuno-Compromised Healthy Elderly Subjects 93
Liver fibrosis: evaluation with diffusion-weighted magnetic resonance imaging in patients with chronic liver disease 93
Safety and more compliance of colonoscopy with external straightner 93
Prevalence of anti-CagA reactivity in Helicobacter Pylori positive patients 90
Lactose intolerance: An update on its pathogenesis, diagnosis, and treatment 90
Prevalence of hepatitis E and hepatitis B dual infection in North India (Delhi) 89
Clinical importance of lactic acid bacteria: a short review 89
Omeprazole plus clarithromycin: efficacy of two treatment regimens on Helicobacter pylori positive duodenal ulcer 89
Helicobacter pylori ed epatopatia cronica B e C 89
Protection By Copper (Cu++) Against Ethanol-Induced Gastric Mucosal Injury In The Rat 88
Environmental and dietary metabolic stress in workers: Novel avenues in oral heavy metal chelation and fatty liver aids 88
HP positive duodenal ulcer: three day antibiotic eradicating treatment 88
IgG anti-Helicobacter Pylori e pepsinogeni sierici in pazienti ulcerosi duodenali HP+ e in dispeptici HP- 88
Sintomi indicativi della dispepsia non-ulcerosa Helicobacter pylori positiva 87
Omeprazolo e Bismuto Subcitrato Colloidale nella dispepsia non ulcerosa HP positiva 87
Testing a novel bioactive marine nutraceutical on osteoarthritis patients 85
Inhibiting insulin resistance mechanisms by DTS phytocompound: an experimental study on metabolic syndrome-prone adipocytes 85
Duodenal Ulcer And Functional Dyspepsia: Different Susceptibility Of Helicobacter Pylori To Eradicating Therapy 85
Ranitidine bismuth citrate versus omeprazole triple therapy for the eradication of Helicobacter pylori and healing of duodenal ulcer 84
Diagnostic accuracy of enhanced liver fibrosis test to assess liver fibrosis in patients with chronic hepatitis C 84
Comparative treatment of Helicobacter pylori-positive duodenal ulcer using pantoprazole at low and high doses versus omeprazole in triple therapy 84
FIB-4 and APRI scores for predicting severe liver fibrosis in chronic hepatitis HCV patients: a monocentric retrospective study 84
Indicative symptoms for Helicobacter pylori positive non-ulcer dyspepsia 84
Comparison of 5-ASA plus sucralfate or hydrocortisone enemas in the treatment of active ulcerative proctitis 84
NAFLD: a sign of "early aging"? 83
Triglycerides to high-density lipoprotein cholesterol ratio for diagnosing nonalcoholic fatty liver disease 83
Novel Nutrigenomics Avenues in Nutraceuticals Use: the Current Status of Fermented Papaya Preparation 82
Iron supplementation in young iron-deficient females causes gastrointestinal redox imbalance: protective effect of a fermented nutraceutical 81
La clebopride nel trattamento della dispepsia funzionale: studio clinico in doppio cieco v/s placebo 81
“Aging Gut Microbiota and Colorectal Cancer Pathways Correlations” 80
Hepatoprotective activity of a phytotherapeutic formula on thioacetamide--induced liver fibrosis model 80
Pancreatic hyperenzymemia: new advances in the field of clinical-diagnostic approach, with particular attention about Gullo's syndrome 80
DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING FOR THE STAGING OF LIVER FIBROSIS: A PRELIMINARY STUDY IN PATIENTS WITH CHRONIC LIVER DISEASE 80
Duodenal Ulcer And Non Ulcer Dyspepsia: First Results Of Helicobacter Pylori Susceptibility To Eradicating Therapy 80
Probiotic approaches for targeting inflammatory bowel disease: an update on advances and opportunities in managing the disease 79
Totale 12.804
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.510
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.510
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021148 0 0 0 0 0 0 0 0 0 0 103 45
2021/20221.234 110 340 13 13 168 18 157 41 91 4 50 229
2022/20231.758 167 64 40 150 164 300 18 283 422 19 82 49
2023/2024988 64 102 51 64 75 204 42 46 23 43 172 102
2024/20253.333 47 414 215 132 840 442 122 166 273 272 217 193
2025/20266.729 325 215 2.127 375 980 1.075 758 163 300 328 83 0
Totale 16.513